home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Identifying The Function Of p110-alpha AOP

 
  April, 26 2006 9:15
your information resource in human molecular genetics
 
     
The family of mammalian enzymes called phosphoinositide-3-OH kinases (PI(3)K) are fundamental cell signalling molecules whose exact roles have been difficult to pin down. Bart Vanhaesebroeck and colleagues show in a paper published online by Nature that one form of this enzyme, p110-alpha PI(3)K, is vital for cell growth and metabolism, findings that may help to explain why it is mutated in a variety of cancers.

The team tested the role of p110-alpha by genetically engineering mice so that the enzyme was still manufactured at normal levels but no longer active. Mice carrying one copy of the defective gene did not respond normally to the hormones insulin, insulin-like growth factor-1 and leptin, and exhibited a range of growth and metabolic disorders as a result.

The study suggests that cancer cells may hijack cell growth pathways by increasing activation of p110-alpha, and supports the idea that blocking p110-alpha could block cancer growth.

CONTACT

Bart Vanhaesebroeck (Ludwig Institute for Cancer Research, London, UK)
E-mail: bartvanh@ludwig.ucl.ac.uk

Abstract available online.

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.